Ardena

Ardena Expands European Bioanalytical Capabilities

Belgium-headquartered pharmaceutical contract development and manufacturing organization (CDMO) Ardena announced plans to expand its bioanalytical services in the Netherlands. As part of the investment, the company plans to establish a new bioanalytical laboratory at its Pivot Park facility in Oss, as well as additional capacity and new GLP capabilities at its bioanalytical center of excellence in Assen.

Experts Statements: Harry Christiaens, Ardena

The Pharma CDMO Challenge

Ardena Launches Life Science Ingredients Arm